The famed income investor Neil Woodford has put almost 8% of his flagship fund’s money into one company, AstraZeneca (LSE: AZN). Here are five reasons why he’s so confident that this investment will work out for him and his investors.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.
VIDEO: One Fool takes a closer look at AstraZeneca plc (LON:AZN).
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.
The famed income investor Neil Woodford has put almost 8% of his flagship fund’s money into one company, AstraZeneca (LSE: AZN). Here are five reasons why he’s so confident that this investment will work out for him and his investors.